GJA1 and ischemic stroke: Ischemic stroke studies have reported beneficial results by specific inhibition of Cx43 in in vitro models (Chew et al., 2010) and general gap junction inhibition in vivo (Perez Velazquez et al., 2006; Andersson et al., 2011).